PRKDC and cancer: Noteworthy to mention that the drug discovery endeavours employed robust drug design strategies and culminated into a plethora of tractable ATM/ATR/DNA-PK inhibitors that on exhaustive explorations might emerge as cancer therapeutics in the long run.